August 1, 2011
MILFORD, Mass. - SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that its Board of Directors has initiated a process to explore and evaluate potential strategic alternatives for the Company to enhance shareholder value, which [...]
New Rapid Western Blotting Kits from AMRESCO, LLC Expand Primary Antibody Compatibility
July 31, 2011
Solon, Ohio - The streamlined simplicity of AMRESCO’s Rapid Western Blotting Kits for use with mouse and rabbit primary antibodies debuted last year to a welcome reception. Dr. Patricia DiBello at the Cleveland Clinic said, “[AMRESCO’s Rapid Western Blottting Kits] are easy to use and have greatly reduced the time I have to spend doing [...]
Thermo Fisher Scientific and Agere Pharmaceuticals Collaborate to Offer
July 29, 2011
NEWINGTON, N.H. – Thermo Fisher Scientific Inc., the world leader in serving science, today announced a cooperation agreement with Agere Pharmaceuticals Inc., which will enable customers to accelerate formulation development of pharmaceutical compounds. The partnership is intended to reduce time and cost during proof of concept studies by means of hot melt extrusion and granulation. [...]
Topcon announces versatile, hybrid microscope
July 29, 2011
LIVERMORE, Calif. – Topcon Positioning Systems (TPS), a global leader in precision optical, GPS, and automation systems for geodetic, engineering and construction applications, has introduced the Aquila hybrid microscope to the North American market. Ray O’Connor, TPS president and CEO, said, “The Aquila hybrid scope puts the versatility of an optical microscope and the power [...]
July 29, 2011
ST. LOUIS, MO - MOgene, LC, a leading genomics service provider headquartered in St. Louis, MO, announced today the offering of new extra-long reads on Roche's 454 GS FLX+ next generation sequencing platform. MOgene is one of the first companies in the USA to offer this long read sequencing upgrade which delivers millions of bases [...]
JEOL New Company Set up and Operational in India
July 29, 2011
Having observed the acceleration occurring on scientific importance and business potentials, JEOL Ltd. (Gon-emon Kurihara, President) has opened a new company dedicated to Analytical Instruments (NMR, ESR, Mass Spectrometer) in India on the 1st of June, aimed at offering enhanced support of excellence. Blue Star Limited remains our agent, but will focus on Electron Optics [...]
OriGene Technologies Reaches 3000 TrueMAB™ Monoclonal Antibodies
July 29, 2011
ROCKVILLE, Md. - OriGene Technologies, Inc. a gene-centric life sciences company, today announced that through its July release, the TrueMAB™ monoclonal antibodies have reached the 3000 product milestone. Each TrueMAB, made against antigens produced mostly in HEK293T cells, has proven superior in performance for immunoassays that are sensitive to proteins' native conformations. The development further [...]
NEW WHEATON Guide Highlights BioBanking Solutions™
July 28, 2011
WHEATON, the company that designs and delivers today’s most innovative solutions for the laboratory research, diagnostic packaging and specialty pharmaceuticals industries, is pleased to introduce the new Biobanking Solutions Guide. Created as a tool to aid researchers in making their jobs easier and more efficient when storing and accessing irreplaceable biological samples, the WHEATON BioBanking [...]
July 28, 2011
PENZBERG, Germany - RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype, as it is not possible to measure developmental changes over time. To address this, a research team led by Stefan Wiemann and Ulrich Tschulena in the Division Molecular Genome Analysis [...]
Roka Bioscience Completes $20 Million Series C Financing
July 28, 2011
WARREN, N.J. - Roka Bioscience, Inc. announced today that it recently completed a Series C round of equity financing, raising $20 million in new capital. The financing brings the total amount raised to $57.2 million since the company's formation in September 2009. The investor syndicate included participation from all existing investors including OrbiMed Advisors, New [...]
